Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 19

1.

Dysfunction of endothelial protein C activation in severe meningococcal sepsis.

Faust SN, Levin M, Harrison OB, Goldin RD, Lockhart MS, Kondaveeti S, Laszik Z, Esmon CT, Heyderman RS.

N Engl J Med. 2001 Aug 9;345(6):408-16.

2.

Endogenous protein C activation in patients with severe sepsis.

Liaw PC.

Crit Care Med. 2004 May;32(5 Suppl):S214-8. Review.

PMID:
15118520
3.

The protein C pathway.

Esmon CT.

Chest. 2003 Sep;124(3 Suppl):26S-32S. Review.

PMID:
12970121
4.

Surgical interventions in children with meningococcal purpura fulminans--a review of 117 procedures in 21 children.

Wheeler JS, Anderson BJ, De Chalain TM.

J Pediatr Surg. 2003 Apr;38(4):597-603. Review.

PMID:
12677574
5.

Soluble thrombomodulin, plasma-derived unactivated protein C, and recombinant human activated protein C in sepsis.

Dhainaut JF, Yan SB, Cariou A, Mira JP.

Crit Care Med. 2002 May;30(5 Suppl):S318-24. Review.

PMID:
12004254
6.

[Endothelial cells and coagulation abnormalities].

Uchiba M, Okajima K.

Rinsho Byori. 2000 Apr;48(4):308-13. Review. Japanese.

PMID:
10810875
7.

Protein C replacement in severe meningococcemia: rationale and clinical experience.

Alberio L, Lämmle B, Esmon CT.

Clin Infect Dis. 2001 May 1;32(9):1338-46. Epub 2001 Apr 9. Review. Erratum in: Clin Infect Dis 2001 Jun 15;32(12):1803.

PMID:
11303270
8.

Purpura fulminans in sepsis.

Betrosian AP, Berlet T, Agarwal B.

Am J Med Sci. 2006 Dec;332(6):339-45. Review.

PMID:
17170624
9.

Coagulation in severe sepsis: a central role for thrombomodulin and activated protein C.

Faust SN, Heyderman RS, Levin M.

Crit Care Med. 2001 Jul;29(7 Suppl):S62-7; discussion S67-8. Review.

PMID:
11445736
10.

Activated protein C versus protein C in severe sepsis.

Yan SB, Dhainaut JF.

Crit Care Med. 2001 Jul;29(7 Suppl):S69-74. Review.

PMID:
11445737
11.

Invasive meningococcal disease: a disease of the endothelial cells.

Coureuil M, Bourdoulous S, Marullo S, Nassif X.

Trends Mol Med. 2014 Oct;20(10):571-8. doi: 10.1016/j.molmed.2014.08.002. Epub 2014 Aug 29. Review.

PMID:
25178566
12.

[Cutaneous vasculitis during bacteremia caused by Meningococcus serogroup B].

García-Patos V, Barnadas MA, Domingo P, Esquius J, de Moragas JM.

Rev Clin Esp. 1992 Apr;190(6):311-3. Review. Spanish.

PMID:
1598431
13.

Pathogenesis of meningococcal purpura fulminans.

Lécuyer H, Borgel D, Nassif X, Coureuil M.

Pathog Dis. 2017 Apr 1;75(3). doi: 10.1093/femspd/ftx027. Review.

PMID:
28334263
14.

Protein C.

Esmon CT.

Prog Hemost Thromb. 1984;7:25-54. Review.

PMID:
6099583
15.

Infectious purpura fulminans: diagnosis and treatment.

Smith OP, White B.

Br J Haematol. 1999 Feb;104(2):202-7. Review. No abstract available.

PMID:
10050699
16.

Acute infectious purpura fulminans: pathogenesis and medical management.

Darmstadt GL.

Pediatr Dermatol. 1998 May-Jun;15(3):169-83. Review.

PMID:
9655311
17.

[Sepsis-associated coagulation disorders].

Dempfle CE.

Hamostaseologie. 2005 May;25(2):183-9. Review. German.

PMID:
15924156
18.

Rapid recovery of acquired purpura fulminans in a patient with familial C4bBP deficiency.

Lemesle FG, Gris JC, Schwed JF, Arich C.

Intensive Care Med. 1993;19(2):115-6. Review.

PMID:
8486865
19.

[Regulation of anticoagulant activity and expression of thrombomodulin].

Ishii H.

Seikagaku. 1995 Apr;67(4):307-12. Review. Japanese. No abstract available.

PMID:
7602206

Supplemental Content

Support Center